Last kr76.75 SEK
Change Today +0.65 / 0.85%
Volume 681.1K
SOBI On Other Exchanges
Symbol
Exchange
Stockholm
Berlin
OTC US
OTC US
As of 11:29 AM 09/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Cameron Geoffrey McDonough M.D.

Chief Executive Officer and President, Swedish Orphan Biovitrum AB
AgeTotal Calculated CompensationThis person is connected to 14 board members in 1 different organizations across 3 different industries.

See Board Relationships
44kr9,549,000
As of Fiscal Year 2013

Background*

Dr. Cameron Geoffrey McDonough, also known as Geoff, has been the Chief Executive Officer and President at Swedish Orphan Biovitrum AB since August 15, 2011. Dr. McDonough has been with Sobi since August 2011. He also held several senior leadership positions at Genzyme Corporation from 2002 to 2011 including as its President of Organization in Europe since May 2010 and demonstrated strong leadership of its Personalized Genetic Health business during a challenging period. ...

Read Full Background

Corporate Headquarters*

Tomtebodavägen 23 A
Stockholm, Stockholm County 112 76

Sweden

Phone: 46 86 97 20 00
Fax: 46 86 97 23 30

Board Members Memberships*

2012-Present
Director

Education*

MD
Harvard Medical School
BA
University of North Carolina
BS
University of North Carolina

Other Affiliations*

Annual Compensation*

Salarykr3,240,000
Bonuskr1,102,000
Total Annual Compensationkr4,342,000

Stock Options*

All Other Compensationkr5,207,000

Total Compensation*

Total Annual Cash Compensationkr9,549,000
Total Short Term Compensationkr4,342,000
Other Long Term Compensationkr5,207,000
Total Calculated Compensationkr9,549,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SOBI:SS kr76.75 SEK +0.65

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Sijmen de Vries M.D., MBAChief Executive Officer and Member of Management Board
Pharming Group NV
€546.0K
John Dawson Chief Executive Officer and Director
Oxford BioMedica PLC
429.0K GBP
Edwin Moses Ph.D.Chief Executive Officer and Director
Ablynx NV
--
William J. Polvino M.D.Chief Executive Officer and President
Veloxis Pharmaceuticals A/S
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SWEDISH ORPHAN BIOVITRUM AB, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.